<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-08-04 23:26:42Medicine Clinical medicine Health Tyrosine kinase inhibitors Clinical pharmacology Breakthrough therapy Nintedanib Piperazines Thrombocytopenia Kasumigaseki Package insert Adverse effect |
|
Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl